WellPoint Agrees to Pay for 3 Children to Get Heart Gene Test

WellPoint Inc. said it will pay for DNA testing for three children to see if they have an inherited heart disease their father suffers from that often strikes without warning, reversing an earlier decision to deny coverage.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.